{"entity":{"type":"insider","cik":"0001379970","url":"/insider/0001379970","json_url":"/insider/0001379970.json","name":"GILMAN STEVEN C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":43,"first":"2010-05-18","last":"2024-10-18","span_basis":"filed_date"},"name_variants":[{"name":"GILMAN STEVEN C","source":"filing","n_filings":43,"first_seen":"2010-05-18","last_seen":"2024-10-18"}],"transactions":[{"id":2054406,"accession":"0001140361-24-043695","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-24-043695","line_url":"/filing/0001140361-24-043695#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5833.0,"shares_display":"5,833","price_per_share":41.36,"price_display":"41.36","price_state":"stated","total_value":241252.88,"total_display":"241,252.88","total_whole":"241,253","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":3035369,"accession":"0001140361-24-042882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-24-042882","line_url":"/filing/0001140361-24-042882#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5833.0,"shares_display":"5,833","price_per_share":40.35,"price_display":"40.35","price_state":"stated","total_value":235361.55,"total_display":"235,361.55","total_whole":"235,362","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-02","filed_date":"2024-10-04","scope":"insider"},{"id":2423039,"accession":"0001140361-24-041562","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-24-041562","line_url":"/filing/0001140361-24-041562#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5834.0,"shares_display":"5,834","price_per_share":45.54,"price_display":"45.54","price_state":"stated","total_value":265680.36,"total_display":"265,680.36","total_whole":"265,680","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-18","filed_date":"2024-09-20","scope":"insider"},{"id":2980689,"accession":"0001140361-24-040228","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-24-040228","line_url":"/filing/0001140361-24-040228#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":48.58,"price_display":"48.58","price_state":"stated","total_value":242900.0,"total_display":"242,900.00","total_whole":"242,900","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-04","filed_date":"2024-09-05","scope":"insider"},{"id":6937216,"accession":"0001562180-22-004870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-004870","line_url":"/filing/0001562180-22-004870#line-1","is_derivative":false,"issuer_cik":"0001379970","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001379970","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4567.0,"shares_display":"4,567","price_per_share":0.362,"price_display":"0.36","price_state":"stated","total_value":1653.254,"total_display":"1,653.25","total_whole":"1,653","shares_owned_after":43430.0,"shares_owned_after_display":"43,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-07","scope":"insider"},{"id":6228241,"accession":"0001593968-22-000897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-22-000897","line_url":"/filing/0001593968-22-000897#line-1","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":30.94,"price_display":"30.94","price_state":"stated","total_value":27846.0,"total_display":"27,846.00","total_whole":"27,846","shares_owned_after":5200.0,"shares_owned_after_display":"5,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-02","scope":"insider"},{"id":5077868,"accession":"0001593968-21-002478","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002478","line_url":"/filing/0001593968-21-002478#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":39.171,"price_display":"39.17","price_state":"stated","total_value":195855.0,"total_display":"195,855.00","total_whole":"195,855","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-12-01","scope":"insider"},{"id":5122904,"accession":"0001593968-21-002304","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002304","line_url":"/filing/0001593968-21-002304#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":50.574,"price_display":"50.57","price_state":"stated","total_value":252870.0,"total_display":"252,870.00","total_whole":"252,870","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-27","filed_date":"2021-10-28","scope":"insider"},{"id":4242888,"accession":"0001593968-21-002214","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002214","line_url":"/filing/0001593968-21-002214#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":48.851,"price_display":"48.85","price_state":"stated","total_value":244255.0,"total_display":"244,255.00","total_whole":"244,255","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-30","filed_date":"2021-10-01","scope":"insider"},{"id":4725496,"accession":"0001562180-21-004152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-21-004152","line_url":"/filing/0001562180-21-004152#line-1","is_derivative":false,"issuer_cik":"0001379970","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001379970","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4567.0,"shares_display":"4,567","price_per_share":3.3202,"price_display":"3.32","price_state":"stated","total_value":15163.3534,"total_display":"15,163.35","total_whole":"15,163","shares_owned_after":47997.0,"shares_owned_after_display":"47,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider"},{"id":2799240,"accession":"0001209191-20-064956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-064956","line_url":"/filing/0001209191-20-064956#line-1","is_derivative":false,"issuer_cik":"0001178253","issuer_name":"SCYNEXIS INC","issuer_ticker":"SCYX","issuer_name_source":null,"issuer_url":"/issuer/0001178253","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-23","scope":"insider"},{"id":2355429,"accession":"0001179110-20-008799","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008799","line_url":"/filing/0001179110-20-008799#line-2","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":32.75,"price_display":"32.75","price_state":"stated","total_value":425750.0,"total_display":"425,750.00","total_whole":"425,750","shares_owned_after":7796.0,"shares_owned_after_display":"7,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-07","scope":"insider"},{"id":3054067,"accession":"0001179110-20-008585","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008585","line_url":"/filing/0001179110-20-008585#line-2","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":29.7,"price_display":"29.70","price_state":"stated","total_value":297000.0,"total_display":"297,000.00","total_whole":"297,000","shares_owned_after":7796.0,"shares_owned_after_display":"7,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-29","filed_date":"2020-07-30","scope":"insider"},{"id":3053969,"accession":"0001179110-20-008471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008471","line_url":"/filing/0001179110-20-008471#line-2","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":33.23,"price_display":"33.23","price_state":"stated","total_value":332300.0,"total_display":"332,300.00","total_whole":"332,300","shares_owned_after":7796.0,"shares_owned_after_display":"7,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-22","filed_date":"2020-07-23","scope":"insider"},{"id":2712740,"accession":"0001562180-20-004359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-004359","line_url":"/filing/0001562180-20-004359#line-2","is_derivative":false,"issuer_cik":"0001379970","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001379970","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4567.0,"shares_display":"4,567","price_per_share":12.08,"price_display":"12.08","price_state":"stated","total_value":55169.36,"total_display":"55,169.36","total_whole":"55,169","shares_owned_after":38864.0,"shares_owned_after_display":"38,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-09","scope":"insider"},{"id":8428873,"accession":"0001562180-19-005642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-005642","line_url":"/filing/0001562180-19-005642#line-1","is_derivative":false,"issuer_cik":"0001379970","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001379970","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5800.0,"shares_display":"5,800","price_per_share":3.43,"price_display":"3.43","price_state":"stated","total_value":19894.0,"total_display":"19,894.00","total_whole":"19,894","shares_owned_after":29731.0,"shares_owned_after_display":"29,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-22","scope":"insider"},{"id":8611138,"accession":"0001593968-19-001035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-19-001035","line_url":"/filing/0001593968-19-001035#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":16.8126,"price_display":"16.81","price_state":"stated","total_value":126094.5,"total_display":"126,094.50","total_whole":"126,095","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-01","filed_date":"2019-05-03","scope":"insider"},{"id":8140309,"accession":"0001593968-19-000610","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-19-000610","line_url":"/filing/0001593968-19-000610#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":18.0172,"price_display":"18.02","price_state":"stated","total_value":135129.0,"total_display":"135,129.00","total_whole":"135,129","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-28","filed_date":"2019-03-04","scope":"insider"},{"id":6598591,"accession":"0001593968-18-001531","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-18-001531","line_url":"/filing/0001593968-18-001531#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":17.7539,"price_display":"17.75","price_state":"stated","total_value":150908.15,"total_display":"150,908.15","total_whole":"150,908","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-04","scope":"insider"},{"id":6506037,"accession":"0001593968-18-001169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-18-001169","line_url":"/filing/0001593968-18-001169#line-2","is_derivative":false,"issuer_cik":"0000887359","issuer_name":"Vericel Corp","issuer_ticker":"VCEL","issuer_name_source":null,"issuer_url":"/issuer/0000887359","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":108270.0,"total_display":"108,270.00","total_whole":"108,270","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":6122764,"accession":"0001179110-18-009059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-009059","line_url":"/filing/0001179110-18-009059#line-1","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2294.0,"shares_display":"2,294","price_per_share":21.5,"price_display":"21.50","price_state":"stated","total_value":49321.0,"total_display":"49,321.00","total_whole":"49,321","shares_owned_after":3440.0,"shares_owned_after_display":"3,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-22","filed_date":"2018-06-26","scope":"insider"},{"id":6605778,"accession":"0001114220-18-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000062","line_url":"/filing/0001114220-18-000062#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1334.0,"shares_display":"1,334","price_per_share":5.12,"price_display":"5.12","price_state":"stated","total_value":6830.08,"total_display":"6,830.08","total_whole":"6,830","shares_owned_after":17333.0,"shares_owned_after_display":"17,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-11","filed_date":"2018-06-12","scope":"insider"},{"id":6520550,"accession":"0001114220-18-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001114220-18-000059","line_url":"/filing/0001114220-18-000059#line-1","is_derivative":false,"issuer_cik":"0001114220","issuer_name":"KERYX BIOPHARMACEUTICALS INC","issuer_ticker":"KERX","issuer_name_source":null,"issuer_url":"/issuer/0001114220","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1333.0,"shares_display":"1,333","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":6958.26,"total_display":"6,958.26","total_whole":"6,958","shares_owned_after":18667.0,"shares_owned_after_display":"18,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-29","filed_date":"2018-05-31","scope":"insider"},{"id":4083988,"accession":"0001209191-17-046310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-046310","line_url":"/filing/0001209191-17-046310#line-1","is_derivative":false,"issuer_cik":"0001379970","issuer_name":"CONTRAFECT Corp","issuer_ticker":"CFRX","issuer_name_source":null,"issuer_url":"/issuer/0001379970","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":1.24,"price_display":"1.24","price_state":"stated","total_value":992.0,"total_display":"992.00","total_whole":"992","shares_owned_after":20800.0,"shares_owned_after_display":"20,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-25","filed_date":"2017-07-26","scope":"insider"},{"id":3085133,"accession":"0001209191-16-134126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-134126","line_url":"/filing/0001209191-16-134126#line-1","is_derivative":false,"issuer_cik":"0001379970","issuer_name":"CONTRAFECT Corp","issuer_ticker":"CFRX","issuer_name_source":null,"issuer_url":"/issuer/0001379970","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.48,"price_display":"2.48","price_state":"stated","total_value":49600.0,"total_display":"49,600.00","total_whole":"49,600","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-27","filed_date":"2016-07-27","scope":"insider"},{"id":6602974,"accession":"0001127602-14-029076","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-14-029076","line_url":"/filing/0001127602-14-029076","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48125.0,"shares_display":"48,125","price_per_share":65.38617942857142,"price_display":"65.39","price_state":"stated","total_value":3146709.885,"total_display":"3,146,709.88","total_whole":"3,146,710","shares_owned_after":50223.0,"shares_owned_after_display":"50,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-02","scope":"insider","n_lines":3},{"id":6551175,"accession":"0001127602-14-024045","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-14-024045","line_url":"/filing/0001127602-14-024045","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40625.0,"shares_display":"40,625","price_per_share":61.56564153846154,"price_display":"61.57","price_state":"stated","total_value":2501104.1875,"total_display":"2,501,104.19","total_whole":"2,501,104","shares_owned_after":34123.0,"shares_owned_after_display":"34,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-28","filed_date":"2014-07-29","scope":"insider","n_lines":2},{"id":6278682,"accession":"0001127602-14-017670","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-14-017670","line_url":"/filing/0001127602-14-017670","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16340.0,"shares_display":"16,340","price_per_share":67.82372429620563,"price_display":"67.82","price_state":"stated","total_value":1108239.655,"total_display":"1,108,239.66","total_whole":"1,108,240","shares_owned_after":33823.0,"shares_owned_after_display":"33,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-15","filed_date":"2014-05-15","scope":"insider","n_lines":3},{"id":6397391,"accession":"0001127602-14-017474","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-14-017474","line_url":"/filing/0001127602-14-017474#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1680.0,"shares_display":"1,680","price_per_share":69.0,"price_display":"69.00","price_state":"stated","total_value":115920.0,"total_display":"115,920.00","total_whole":"115,920","shares_owned_after":26313.0,"shares_owned_after_display":"26,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-14","filed_date":"2014-05-14","scope":"insider"},{"id":6631970,"accession":"0001127602-14-007067","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-14-007067","line_url":"/filing/0001127602-14-007067#line-3","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2645.0,"shares_display":"2,645","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":198375.0,"total_display":"198,375.00","total_whole":"198,375","shares_owned_after":24493.0,"shares_owned_after_display":"24,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider"},{"id":9227303,"accession":"0001127602-14-000159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-14-000159","line_url":"/filing/0001127602-14-000159","is_derivative":false,"issuer_cik":"0001379970","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0001379970","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":67.81773392,"price_display":"67.82","price_state":"stated","total_value":1695443.348,"total_display":"1,695,443.35","total_whole":"1,695,443","shares_owned_after":23288.0,"shares_owned_after_display":"23,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-02","scope":"insider","n_lines":2},{"id":6571796,"accession":"0001127602-14-000151","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001127602-14-000151","line_url":"/filing/0001127602-14-000151","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":67.81773392,"price_display":"67.82","price_state":"stated","total_value":1695443.348,"total_display":"1,695,443.35","total_whole":"1,695,443","shares_owned_after":24050.0,"shares_owned_after_display":"24,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-02","scope":"insider","n_lines":2},{"id":4224015,"accession":"0001127602-13-019124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-019124","line_url":"/filing/0001127602-13-019124#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15125.0,"shares_display":"15,125","price_per_share":54.4928,"price_display":"54.49","price_state":"stated","total_value":824203.6,"total_display":"824,203.60","total_whole":"824,204","shares_owned_after":23507.0,"shares_owned_after_display":"23,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-03","filed_date":"2013-06-03","scope":"insider"},{"id":5119091,"accession":"0001127602-13-017258","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-017258","line_url":"/filing/0001127602-13-017258#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1201.0,"shares_display":"1,201","price_per_share":48.8758,"price_display":"48.88","price_state":"stated","total_value":58699.8358,"total_display":"58,699.84","total_whole":"58,700","shares_owned_after":23507.0,"shares_owned_after_display":"23,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-16","filed_date":"2013-05-17","scope":"insider"},{"id":4820927,"accession":"0001127602-13-017086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-017086","line_url":"/filing/0001127602-13-017086#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1017.0,"shares_display":"1,017","price_per_share":48.4147,"price_display":"48.41","price_state":"stated","total_value":49237.7499,"total_display":"49,237.75","total_whole":"49,238","shares_owned_after":22208.0,"shares_owned_after_display":"22,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-15","filed_date":"2013-05-16","scope":"insider"},{"id":5410765,"accession":"0001127602-13-016917","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-016917","line_url":"/filing/0001127602-13-016917#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1135.0,"shares_display":"1,135","price_per_share":49.1791,"price_display":"49.18","price_state":"stated","total_value":55818.2785,"total_display":"55,818.28","total_whole":"55,818","shares_owned_after":20725.0,"shares_owned_after_display":"20,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-14","filed_date":"2013-05-15","scope":"insider"},{"id":4435457,"accession":"0001127602-13-006939","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-006939","line_url":"/filing/0001127602-13-006939#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1233.0,"shares_display":"1,233","price_per_share":41.4003,"price_display":"41.40","price_state":"stated","total_value":51046.5699,"total_display":"51,046.57","total_whole":"51,047","shares_owned_after":18360.0,"shares_owned_after_display":"18,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-19","filed_date":"2013-02-20","scope":"insider"},{"id":5558079,"accession":"0001127602-13-000546","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-13-000546","line_url":"/filing/0001127602-13-000546#line-3","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":42.983,"price_display":"42.98","price_state":"stated","total_value":644745.0,"total_display":"644,745.00","total_whole":"644,745","shares_owned_after":15843.0,"shares_owned_after_display":"15,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-02","filed_date":"2013-01-03","scope":"insider"},{"id":2485525,"accession":"0001127602-12-017232","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-017232","line_url":"/filing/0001127602-12-017232#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":41.5733,"price_display":"41.57","price_state":"stated","total_value":831466.0,"total_display":"831,466.00","total_whole":"831,466","shares_owned_after":18379.0,"shares_owned_after_display":"18,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-17","filed_date":"2012-05-17","scope":"insider"},{"id":2105829,"accession":"0001127602-12-017000","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-12-017000","line_url":"/filing/0001127602-12-017000#line-4","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":798.0,"shares_display":"798","price_per_share":41.85,"price_display":"41.85","price_state":"stated","total_value":33396.3,"total_display":"33,396.30","total_whole":"33,396","shares_owned_after":18379.0,"shares_owned_after_display":"18,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-16","filed_date":"2012-05-16","scope":"insider"},{"id":2105828,"accession":"0001127602-12-017000","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-12-017000","line_url":"/filing/0001127602-12-017000#line-3","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":799.0,"shares_display":"799","price_per_share":41.9012,"price_display":"41.90","price_state":"stated","total_value":33479.0588,"total_display":"33,479.06","total_whole":"33,479","shares_owned_after":19177.0,"shares_owned_after_display":"19,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-15","filed_date":"2012-05-16","scope":"insider"},{"id":2455391,"accession":"0001127602-12-016878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-016878","line_url":"/filing/0001127602-12-016878#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1135.0,"shares_display":"1,135","price_per_share":41.5527,"price_display":"41.55","price_state":"stated","total_value":47162.3145,"total_display":"47,162.31","total_whole":"47,162","shares_owned_after":14976.0,"shares_owned_after_display":"14,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-14","filed_date":"2012-05-15","scope":"insider"},{"id":9083880,"accession":"0001127602-11-027824","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-11-027824","line_url":"/filing/0001127602-11-027824#line-3","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379970","owner_name":"GILMAN STEVEN C","owner_display_name":"GILMAN STEVEN C","owner_url":"/insider/0001379970","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71250.0,"shares_display":"71,250","price_per_share":38.7031,"price_display":"38.70","price_state":"stated","total_value":2757595.875,"total_display":"2,757,595.88","total_whole":"2,757,596","shares_owned_after":12480.0,"shares_owned_after_display":"12,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-26","filed_date":"2011-10-28","scope":"insider"}],"collapsed":true,"next_cursor":"2011-10-26|9083880","ledger_fault":false,"count":{"value":51,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":51},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000887359","name":"Vericel Corp","url":"/issuer/0000887359","role":"Director","n_filings":12,"first_seen":"2018-09-06","last_seen":"2024-10-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001517022","name":"Akebia Therapeutics, Inc.","url":"/issuer/0001517022","role":"Director","n_filings":4,"first_seen":"2019-11-22","last_seen":"2022-06-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001178253","name":"SCYNEXIS INC","url":"/issuer/0001178253","role":"Director","n_filings":1,"first_seen":"2020-12-23","last_seen":"2020-12-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001235010","name":"MOMENTA PHARMACEUTICALS INC","url":"/issuer/0001235010","role":"Director","n_filings":4,"first_seen":"2018-06-26","last_seen":"2020-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001114220","name":"KERYX BIOPHARMACEUTICALS INC","url":"/issuer/0001114220","role":"Director","n_filings":2,"first_seen":"2018-05-31","last_seen":"2018-06-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001478069","name":"CONTRAFECT Corp","url":"/issuer/0001478069","role":"Director, Officer (CEO)","n_filings":2,"first_seen":"2016-07-27","last_seen":"2017-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000912183","name":"CUBIST PHARMACEUTICALS INC","url":"/issuer/0000912183","role":"Officer (EVP & Chief Scientific Officer)","n_filings":18,"first_seen":"2010-05-18","last_seen":"2014-10-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001379970","retrieved_at":"2026-08-26T02:01:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}